NHO Hokkaido Cancer Center

Sapporo, Hokkaido 003-0804

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, First Line Non-Small Cell Lung Cancer

Studies at this site

• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed